Found 5 results
Author Title [ Type(Desc)] Year
Filters: Author is Buggage, RR  [Clear All Filters]
Journal Article
R. R. Buggage, Levy-Clarke, G., Sen, H. N., Ursea, R., Srivastava, S. K., Suhler, E. B., Alternare, C., Velez, G., Ragheb, J., Chan, C., Nussenblatt, R. B., Bamji, A. T., Sran, P., Waldmann, T., and Thompson, D., A Double-Masked, Randomized Study to Investigate the Safety and Efficacy of Daclizumab to Treat the Ocular Complications Related to Behçet's Disease, Ocul Immunol Inflamm, vol. 15, pp. 63-70, 2007.
R. B. Nussenblatt, Peterson, J. S., Foster, C. S., Rao, N. A., See, R. F., Letko, E., and Buggage, R. R., Initial Evaluation of Subcutaneous Daclizumab Treatments for Noninfectious Uveitis: A Multicenter Noncomparative Interventional Case Series, Ophthalmology, vol. 112, pp. 764-770, 2005.
R. B. Nussenblatt, Kim, J., Thompson, D. J. S., Davis, M. D., Chew, E., Ferris, F. L., and Buggage, R. R., Randomized Cinical Trial of Vitamin E in the Treatment of Uveitis-Associated Macular Edema, Am J Ophthalmol, vol. 141, pp. 193-194, 2006.
R. B. Nussenblatt, Rao, N. A., Foster, C. S., Sen, H. N., Srivastava, S., Ursea, R., Li, Z., Thompson, D. J., Peterson, J. S., Robinson, R. R., Shames, R. S., and Buggage, R. R., Subcutaneously administered daclizumab (SC-DAC, humanized anti-IL-2 receptor antibody) therapy for uveitis, 2003.
R. B. Nussenblatt, Rao, N., Foster, C. S., Sen, H. N., Ursea, R., Li, Z., Thompson, D. J., Peterson, J. S., Shames, R. S., and Buggage, R. R., Uveitis therapy: a phase II study using subcutaneously administered daclizumab, 2004.